Trials / Completed
CompletedNCT00379899
ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
A Randomized Study to Evaluate the Effects of Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease (CKD) Receiving Hemodialysis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 360 (actual)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate whether cinacalcet + low dose vitamin D attenuates the progression of vascular calcification over one year, compared with a treatment regimen that includes flexible vitamin D dosing in the absence of cinacalcet, in subjects with chronic kidney disease receiving hemodialysis
Conditions
- Chronic Kidney Disease
- End Stage Renal Disease
- Coronary Artery Calcification
- Vascular Calcification
- Calcification
- Cardiovascular Disease
- Chronic Renal Failure
- Hyperparathyroidism
- Kidney Disease
- Nephrology
- Secondary Hyperparathyroidism
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | cinacalcet | Low dose vitamin D with cinacalcet |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2009-05-01
- Completion
- 2009-11-01
- First posted
- 2006-09-25
- Last updated
- 2014-07-23
- Results posted
- 2010-10-27
Source: ClinicalTrials.gov record NCT00379899. Inclusion in this directory is not an endorsement.